233 related articles for article (PubMed ID: 24517184)
21. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.
Bassus S; Wegert W; Krause M; Escuriola-Ettinghausen C; Siegemund A; Petros S; Scholz T; Scharrer I; Kreuz W; Engelmann L; Kirchmaier CM
Platelets; 2006 Sep; 17(6):378-84. PubMed ID: 16973498
[TBL] [Abstract][Full Text] [Related]
22. In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
Pezeshkpoor B; Gazorpak M; Berkemeier AC; Singer H; Pavlova A; Biswas A; Oldenburg J
Ann Hematol; 2019 Aug; 98(8):1855-1865. PubMed ID: 30997536
[TBL] [Abstract][Full Text] [Related]
23. Thrombin generation and phenotypic correlation in haemophilia A.
Beltrán-Miranda CP; Khan A; Jaloma-Cruz AR; Laffan MA
Haemophilia; 2005 Jul; 11(4):326-34. PubMed ID: 16011583
[TBL] [Abstract][Full Text] [Related]
24. The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.
Yada K; Nogami K; Wakabayashi H; Fay PJ; Shima M
Thromb Haemost; 2013 Jun; 109(6):1007-15. PubMed ID: 23467620
[TBL] [Abstract][Full Text] [Related]
25. Characterization of F8 defects in haemophilia A in Pakistan: investigation of correlation between mutation type and the in vitro thrombin generation assay.
Khanum F; Collins PW; Harris RL; Bowen DJ
Haemophilia; 2014 Mar; 20(2):287-93. PubMed ID: 24118398
[TBL] [Abstract][Full Text] [Related]
26. Cross-reacting Material-positive Hemophilia A Diagnosed in a Patient with a Spontaneous Thigh Hemorrhage.
Saito T; Mukae J; Nakamura Y; Inaba H; Nogami K; Koyama T; Fukutake K; Yamamoto K
Intern Med; 2017; 56(13):1719-1723. PubMed ID: 28674365
[TBL] [Abstract][Full Text] [Related]
27. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study.
Hillarp A; Bowyer A; Ezban M; Persson P; Kitchen S
Haemophilia; 2017 May; 23(3):458-465. PubMed ID: 28198071
[TBL] [Abstract][Full Text] [Related]
28. Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype.
Oldenburg J; Pavlova A
Hamostaseologie; 2010 Nov; 30(4):207-11. PubMed ID: 21057709
[TBL] [Abstract][Full Text] [Related]
29. Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A.
Inaba H; Shinozawa K; Seita I; Otaki M; Suzuki T; Hagiwara T; Amano K; Fukutake K
Int J Hematol; 2013 Jun; 97(6):758-64. PubMed ID: 23625609
[TBL] [Abstract][Full Text] [Related]
30. Normalization of factor VIII levels in a patient with mild haemophilia A during a 35-year period.
Mainwaring CJ; Evans J; Chana J; Lewis H
Haemophilia; 2006 Nov; 12(6):668-71. PubMed ID: 17083519
[TBL] [Abstract][Full Text] [Related]
31. Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays.
Strålfors A; Mikovic D; Schmidt D; Onelöv L; Soutari NMH; Berndtson M; Chaireti R; Holmström M; Antovic JP; Bruzelius M
Thromb Haemost; 2021 Jan; 121(1):27-35. PubMed ID: 32791533
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
[TBL] [Abstract][Full Text] [Related]
33. A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples).
He S; Eelde A; Petrini P; Wallen H; Gabrielsson L; Svensson J; Blombäck M; Holmström M
Thromb Res; 2018 Nov; 171():7-13. PubMed ID: 30216822
[TBL] [Abstract][Full Text] [Related]
34. Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.
d'Oiron R; Pipe SW; Jacquemin M
Haemophilia; 2008 Jul; 14 Suppl 3():138-46. PubMed ID: 18510534
[TBL] [Abstract][Full Text] [Related]
35. Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis.
Samuelson Bannow B; Recht M; Négrier C; Hermans C; Berntorp E; Eichler H; Mancuso ME; Klamroth R; O'Hara J; Santagostino E; Matsushita T; Kessler C
Blood Rev; 2019 May; 35():43-50. PubMed ID: 30922616
[TBL] [Abstract][Full Text] [Related]
36. Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A.
Ninivaggi M; Dargaud Y; van Oerle R; de Laat B; Hemker HC; Lindhout T
J Thromb Haemost; 2011 Aug; 9(8):1549-55. PubMed ID: 21605333
[TBL] [Abstract][Full Text] [Related]
37. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.
Santagostino E; Mancuso ME; Tripodi A; Chantarangkul V; Clerici M; Garagiola I; Mannucci PM
J Thromb Haemost; 2010 Apr; 8(4):737-43. PubMed ID: 20102490
[TBL] [Abstract][Full Text] [Related]
38. Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys).
Trampuš Bakija A; Debeljak M; Preložnik Zupan I; Benedik Dolničar M; Kovač J; Jazbec J
Blood Transfus; 2015 Oct; 13(4):622-30. PubMed ID: 26057490
[TBL] [Abstract][Full Text] [Related]
39. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
Lewis SJ; Stephens E; Florou G; Macartney NJ; Hathaway LS; Knipping J; Collins PW
Br J Haematol; 2007 Sep; 138(6):775-82. PubMed ID: 17672884
[TBL] [Abstract][Full Text] [Related]
40. Factor VIII assay mimicking in vivo coagulation conditions.
Kusch M; Grundmann C; Keitel S; König H
Haemophilia; 2014 Mar; 20(2):e164-70. PubMed ID: 24286249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
